Health

  • August 04, 2026

    Healthcare Fraud Task Force Expands To Philly, Charges 19

    Federal and Pennsylvania law enforcement officials on Tuesday announced charges against 19 defendants involved in home care, alleging they bilked Medicare and Medicaid out of funds meant for caregivers and beneficiaries — representing an expansion of the federal crackdown on benefits fraud to Philadelphia.

  • August 04, 2026

    Kirkland, Jones Day Guide P&G's $3.8B Buy Of Thorne

    Procter & Gamble is acquiring supplements company Thorne from L Catterton for $3.8 billion in cash, with Kirkland & Ellis LLP and Jones Day serving as legal advisers in the transaction, the companies announced Tuesday.

  • August 04, 2026

    Fla. High Court Won't Touch Reversal Of $213M 'Maya' Award

    The Florida Supreme Court said Tuesday it would not hear the appeal of a decision that reversed a $213 million judgment against a Florida hospital in favor of Maya Kowalski, the subject of the Netflix documentary "Take Care of Maya."

  • August 04, 2026

    NYC Retirees Ink $53M In Healthcare Copay Class Action

    New York City and EmblemHealth will pay $53 million to resolve a class action complaint covering more than 250,000 Medicare-eligible retirees who alleged the defendants illegally charged $15 copays onto their healthcare costs, according to a preliminary approval motion filed Friday in New York state court.

  • August 04, 2026

    Judge Undoes Default Order Against Hemp Co. In CBD Oil Suit

    A federal judge set aside a default order against a Washington cannabis grower that failed to timely answer counterclaims in a dispute over a multimillion-dollar hemp biomass purchase agreement, finding the company's late filing was due to attorney and staff error rather than willful misconduct.

  • August 04, 2026

    Modivcare, White & Case Settle Ch. 11 Fee Dispute

    A Texas bankruptcy judge has approved a deal between Modivcare and advisers to its official committee of unsecured creditors, putting to bed turmoil over the committee's $19 million fee application and a connected contempt motion against the reorganized health services group.

  • August 04, 2026

    Workers Say Trump's Gold Card Lets Rich Jump Visa Line

    Professional, skilled workers seeking employment-based visas urged a D.C. federal judge not to toss their lawsuit challenging the gold card visa program, arguing they will suffer injury because the expedited application allows wealthy individuals to skip ahead in line.

  • August 04, 2026

    Foley Hoag DC Office Leader Joins Foley & Lardner

    Foley & Lardner LLP has hired Foley Hoag LLP's former Washington office partner-in-charge, who started her career at that firm as an associate almost 16 years ago, Foley & Lardner announced Tuesday.

  • August 04, 2026

    Rehab Program Participants Seek Collective In Wage Suit

    Former participants in a Texas faith-based addiction recovery program have asked a federal court to certify a collective of workers who allege they were required to perform substantial labor on farms, in retail stores and in other commercial operations without receiving lawful wages, instead earning a points-based system worth roughly $1 per hour.

  • August 04, 2026

    Bellwether Jury Awards $88M In Covidien Hernia Mesh Trial

    A Massachusetts federal jury awarded $88 million Tuesday to a man who claimed he was injured by a Covidien LP-made hernia mesh, in the first case to reach a verdict of thousands pending against the Medtronic unit.

  • August 04, 2026

    Hogan Lovells Adds Arnold & Porter Antitrust Atty In SF

    Hogan Lovells Cadwalader announced on Tuesday that it has added the vice chair of Arnold & Porter Kaye Scholer LLP's tech and media industry group to its San Francisco office, strengthening the firm's antitrust, competition and economic regulation practice.

  • August 03, 2026

    PetMeds Beats Pixel Tracking Privacy Suit Over Standing Flaw

    A Florida federal judge has tossed a proposed class action accusing online pet pharmacy PetMed Express Inc. of deploying tracking tools that illegally transmitted website visitors' data to third parties, finding that class discovery had revealed the plaintiffs lack standing to support their remaining federal and state wiretap claims. 

  • August 03, 2026

    Albertsons Says Wash. Slow To Warn Of Bad Drug Prescribers

    Washington regulators didn't notify pharmacies or patients about doctors' potentially improper opioid prescribing until months after receiving complaints, Albertsons' counsel told a Seattle judge Monday, as the bench trial over Washington's claims the pharmacy chain helped fuel the state's overdose crisis entered its fourth week.

  • August 03, 2026

    Calif. Justices Back Gilead Over Nondefective Drug Liability

    The California Supreme Court on Monday held that Gilead Sciences Inc. shouldn't face a negligence claim alleging it declined to market a safer HIV drug in order to maximize profits from an older drug with more harmful side effects, rejecting a novel theory that would expose drugmakers to broader liability.

  • August 03, 2026

    21 States Again Fight ACA Changes That Could Increase Costs

    A coalition of 21 states sued the U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services in California federal court Friday, challenging an Affordable Care Act rule that shifts costs onto enrollees while reimposing certain provisions that a Maryland federal court vacated for being unlawful and arbitrary.

  • August 03, 2026

    Boeing Mechanic Says Chemicals At Plants Gave Him Cancer

    A mechanic claims his decades of employment at Boeing's Seattle-area manufacturing facilities caused him to develop cancer due to toxic chemical exposures, according to a lawsuit removed by the company to federal court.

  • August 03, 2026

    7th Circ. Backs OB-GYN's 10-Year Healthcare Fraud Sentence

    The Seventh Circuit has upheld a 10-year prison sentence for a former obstetrician-gynecologist over a multimillion-dollar healthcare fraud scheme, saying the district judge made no clear error in applying an enhancement to her sentence for performing invasive and medically unnecessary procedures on patients without their informed consent.

  • August 03, 2026

    Contractor Says HHS, GSA Are Flouting Stay In Contract Row

    A logistics company accused the General Services Administration and the U.S. Department of Health and Human Services of violating federal law by continuing performance on a contract while it's being protested, according to a complaint filed in the U.S. Court of Federal Claims.

  • August 03, 2026

    4 Mass. Rulings You May Have Missed In July

    A Massachusetts judge affirmed her self-described "eye-popping" $91 million judgment against insurance companies, a private lender was freed from fraud claims after a loan recipient's emails told a different story, and a venture capital pro was denied a jury for his upcoming trial, among other recent state court rulings.

  • August 03, 2026

    Novo False-Ad Claims Against Telehealth Co. Fail, For Now

    A New York federal court tossed a false advertising suit by Novo Nordisk against a telehealth company that markets compounded weight loss medications, finding the pharmaceutical giant failed to point to literal or implied false statements made by the company.

  • August 03, 2026

    Monthly Merger Review Snapshot

    A group of state enforcers challenged Paramount's planned $110 billion acquisition of Warner Bros. Discovery, as a separate group of states and DirecTV accused Nexstar of violating an order preventing it from integrating with Tegna and the Federal Trade Commission faced a bench trial seeking to block a constructive adhesive deal.

  • August 03, 2026

    Boston Eye Biz To Pay $3.9M For Improper Medicaid Billing

    A Boston ophthalmology office has agreed to pay $3.9 million to settle allegations it improperly billed Medicare and Medicaid for eye injections performed during office visits, according to a U.S. Department of Justice announcement.

  • August 03, 2026

    4 Firms Steer Curium's $8B Lantheus Take-Private Deal

    Private equity-backed radiopharmaceutical company Curium on Monday announced plans to acquire fellow radiopharmaceutical company Lantheus Holdings Inc. in an $8 billion take-private deal built by four law firms.

  • August 03, 2026

    Sandoz Settles States' Generics Price-Fixing Cases For $450M

    Sandoz reached a settlement with a coalition of state enforcers on Monday, agreeing to pay $450 million to end claims against it in several cases targeting alleged price-fixing in the generic-drug industry.

  • August 03, 2026

    NJ Justices Say Insanity Defense Requires Expert Testimony

    New Jersey's highest court ruled Monday that to raise an insanity or diminished mental capacity defense, a defendant must present testimony from a medical expert that their mental condition caused them to violate the law.

Expert Analysis

  • How The Coming Months Will Shape State Drug Price Boards

    Author Photo

    The future of state prescription drug affordability boards may be determined in the next few months, between an upcoming court decision in a challenge against state authority to set drug prices, and pending state decisions about whether to use federal Medicare maximum fair prices as reference, say Michael Kolber, Steven Chen and Kelechi Ezealaji at Manatt.

  • High Court 'Skinny Label' Case Will Matter To Tech Litigators

    Author Photo

    Hikma v. Amarin, set for oral argument in the U.S. Supreme Court on Wednesday, has potential to affect not just generic drug label-based evidence in patent cases, but also how technology inducement cases are presented and proven, says attorney Abdul Abdullahi.

  • Steps To Consider As DOJ Launches Fraud Division

    Author Photo

    The establishment this month of the National Fraud Enforcement Division within the U.S. Department of Justice is a significant reorganization that suggests an increase in enforcement activity involving federally funded programs but leaves a number of important questions unanswered, say attorneys at Crowell & Moring.

  • Court's HRSA Policy Reversal Leaves 340B Rules Murky

    Author Photo

    A D.C. federal court's recent decision in Premier v. U.S. Department of Health limits the Health Resources and Services Administration's ability to enforce long-standing Section 340B interpretations through subregulatory guidance, leaving open core statutory questions about purchasing models, inventory classification and program oversight, says Martha Cramer at Hooper Lundy.

  • Opinion

    DOJ Delay Of ADA Web Rule Undermines Equal Access

    Author Photo

    The U.S. Department of Justice's recent decision to delay compliance dates for regulations ensuring accessible government services online benefits no one, as it is long overdue for disabled Americans and doesn't lessen covered entities' legal obligations or litigation risk, say Mark Riccobono at the National Federation of the Blind and Eve Hill at Brown Goldstein.

  • Series

    Officiating Football Makes Me A Better Lawyer

    Author Photo

    Though they may seem to have little in common, officiating football has sharpened many of the same skills that define effective lawyering in management-side labor and employment: preparation, judgment, composure, credibility and ability to make difficult decisions in real time, says Josh Nadreau at Fisher Phillips.

  • Fresenius Ruling May Shift Anti-Kickback Enforcement

    Author Photo

    The Ninth Circuit's recent decision in Fresenius v. Bonta suggests that businesses have a First Amendment right to donate to certain charities, even if those donations are motivated by economic self-interest, potentially calling into question years of Anti-Kickback Statute proceedings against pharmaceutical manufacturers for making similar donations, says Jonah Knobler at Patterson Belknap.

  • Written Consent Ruling May Signal Change For Telemarketing

    Author Photo

    The Fifth Circuit's ruling in Bradford v. Sovereign Pest Control is a takedown of the Federal Communications Commission's prior express written consent regulation, and because Loper Bright empowers courts to disregard agency interpretations, Telephone Consumer Protection Act litigants now have an opportunity to challenge previously settled FCC regulations, orders and interpretations, say attorneys at Manatt.

  • Series

    Law School's Missed Lessons: How To Draft Pleadings

    Author Photo

    Most law school graduates step into their first jobs without ever having drafted a complaint, answer, motion or other type of pleading, but that gap can be closed by understanding the strategy embedded in every filing, writing with clarity and purpose, and seeking feedback at every step, says Eric Yakaitis at Haug Barron.

  • E-Discovery Quarterly: Recent Rulings On ESI Control

    Author Photo

    Several recent federal court decisions have perpetuated a split over what constitutes “control” of electronically stored information — with judges divided on whether the standard should turn on a party's legal right or practical ability to obtain the information, say attorneys at Sidley.

  • The Challenge Of Stabilizing Rural Hospitals On The Brink

    Author Photo

    The outlook for rural hospitals has grown more concerning, as recent policy and regulatory developments are decreasing hospital revenues and increasing the cost of uncompensated care, which may result in additional hospital closures, service reductions, or mergers and acquisitions, say Omur Celmanbet, Kristy Piccinini and Sabiha Quddus at FTI Consulting.

  • Insurer Lessons From 1st Wave Of GenAI Coverage Rulings

    Author Photo

    Several pending cases target the issue of whether generative AI may appropriately replace human professional decision-making, and though each case is still in discovery, the decisions thus far provide insurers with guidance on how courts may view these claims, say attorneys at Simpson Thacher.

  • The Role Of Operational Data In Tech Platform Liability Suits

    Author Photo

    As litigation becomes a de facto substitute for the regulation of major technology platforms, with plaintiffs advancing claims under product liability, public nuisance and consumer protection laws, among others, courts are evaluating how platform systems operate in practice based on large-scale operational data, say attorneys at Brattle.

  • 2 Discovery Rulings Break With Heppner On AI Privilege Issue

    Author Photo

    While a New York federal court’s recent ruling in U.S. v. Heppner suggests that some litigants’ communications with AI tools are discoverable, two other recent federal court decisions demonstrate that such interactions generally qualify for work-product protection under the Federal Rules of Civil Procedure, says Joshua Dunn at Brown Rudnick.

  • Bid Protest Spotlight: Evidence, Tailored Talks, Materiality

    Author Photo

    In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Accountability Office about the evidentiary standards necessary to sustain a protest, discussions tailored to individual proposals, and misrepresentation claims involving factors irrelevant to the agency's decision.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.